MarketCapTrends
LMAT

Lemaitre Vascular Inc. (LMAT)

NASDAQ · Healthcare

Lemaitre Vascular Inc. annual/quarterly shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Lemaitre Vascular Inc. shareholder equity for the quarter ending December 31, 2025 were 393.5M, a 16.67% increase year-over-year.
  • Lemaitre Vascular Inc. shareholder equity for 2025 were 393.5M, a 16.67% increase from 2024.
  • Lemaitre Vascular Inc. shareholder equity for 2024 were 337.3M, a 13.22% increase from 2023.
  • Lemaitre Vascular Inc. shareholder equity for 2023 were 297.9M, a 11.07% increase from 2022.
  • Lemaitre Vascular Inc. shareholder equity for 2022 were 268.2M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Lemaitre Vascular Inc. Annual Shareholder Equity (Millions of US $)
2025$394
2024$337
2023$298
2022$268
2021$254
2020$173
2019$148
2018$130
2017$110
2016$88
2015$78
2014$68
2013$57
2012$53
2011$52
Lemaitre Vascular Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$394
2024-12-31$337
2023-12-31$298
2022-12-31$268
2021-12-31$254
2020-12-31$173
2019-12-31$148
2018-12-31$130
2017-12-31$110
2016-12-31$88
2015-12-31$78
2014-12-31$68
2013-12-31$57
2012-12-31$53
2011-12-31$52
2010-12-31$52

Lemaitre Vascular Inc. Shareholder Equity — FAQ

Lemaitre Vascular Inc. (LMAT) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see LMAT's shareholder equity history?

The chart and table above show Lemaitre Vascular Inc.'s shareholder equity by year and by quarter, including the growth rate.